Peripheral blood cellular immunity parameters in COVID-19
https://doi.org/10.25789/YMJ.2022.80.18
Abstract
This article carried material about the results of the investigation of peripheral blood cellular immunity parameters in the COVID-19 patients with ≤30% lung damage hospitalizated in 2020 year. When infected with SARS-CoV-2 on the background of severe lymphopenia and neutrophilia were revealed the multidirectional changing in a cellular immunity parameters, the severity and dynamics of which can be determined by the initial type of immune system response
About the Authors
Zh. P. VasnevaRussian Federation
Vasneva Zhanna P. – PhD, laboratory assistant, Samara Diagnostic Center; Associate Professor of the Department of Laser and Biotechnical Systems of the Samara National Research University
E. A. Borodulina
Russian Federation
Borodulina Elena A. – MD, Professor, head of the Department of Phthisiology and Pulmonology
B. E. Borodulin
Russian Federation
Borodulin Boris E. – MD, Professor of the Department of Phthisiology and Pulmonology,
E. S. Vdoushkina
Russian Federation
Vdoushkina Elizaveta S. – Candidate of Medical Sciences, Associate Professor of the Department of Phthisiology and Pulmonology
A. E. Sukhanova
Russian Federation
Sukhanova Anna E. – resident of the Department of Phthisiology and Pulmonology
References
1. Abdullaev R.YU., Komissarova O.G. Laboratornye proyavleniya koronavirusnoj infekcii COVID-19 [Laboratory manifestations of coronavirus infection]. Vrach (The Doctor). 2020; 31(5):3-5 (In Russ.).]
2. Vdoushkina E.S., Borodulina E.A., Povalyaeva L.V., Sukhanova A.V., Zhilinskaya K.V., Sutyagin A.V. Sroki obrashcheniya i tyazhest' sostoyaniya pacientov s porazheniem legkih i podozreniem na novuyu koronavirusnuyu infekciyu pri postuplenii v stacionar v period nachala pandemii [Terms of treatment and severity of the condition of patients with lung damage and suspected new coronavirus infection upon admission to the hospital during the onset of the pandemic]. Vrach (The Doctor). 2020:31(11):60-63 (In Russ.).]
3. Sizyakina L.P., Zakurskaya V.Ya., Skripkina N.A., Antonova E.A. Uroven' ferritina kak prediktor tyazhelogo techeniya COVID-19. Immunologiya [Immunology. 2021;42(5):518-25 (In Russ.).]
4. Baazim H., Schweiger M, Moschinger M. [et al.] CD8+ T cells induce cachexia during chronic viral infection. Nat Immunol. 2019; 20 (6): 701710.
5. Chen G., Wu D., Guo W [et al.] Clinical and immunological features of severe and moderate coronavirus disease 2019. Clin.Invest. 2020; 130 (5): 2620–2629.
6. Golovkin A., Kalinina O., Bezrukikh V. [et al.] Imbalanced immune response of T – cell and B – cell subsets in patients with moderate and severe COVID-19. Viruses. 2021; 13: 1966.
7. Guan W., Ni Z., Hu Y. [et al.] Clinical Characteristics of Coronavirus Disease 2019 in China. Engl. J. Med. 2020; 382 (18): 1708-1720.
8. Li G., Fan Y, Lai Y [et al.] Coronavirus infections and immune responses. J. Med. Virol. 2020; 92 (4): 424–32.
9. Li Y.X., Wu W., Yang T. [et al.] Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19. Chinese Medical Association Publishing House Ltd. 2020; 59 (5): 372-374.
10. Qin C., Zhou L., Hu Z. [et al.] Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020; 71 (15): 762-768.
11. Ruan Q., Yang K., Wang W. [et al.] Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China Intensive CareMed. 2020; 46 (6):12941297.
12. Saghazadeh A, Rezaei N. Immune-epidemiological parameters of the novel coronavirus – a perspective. Expert Rev. Clin. Immunol. 2020; 16 (5): 465-470
Review
For citations:
Vasneva Zh.P., Borodulina E.A., Borodulin B.E., Vdoushkina E.S., Sukhanova A.E. Peripheral blood cellular immunity parameters in COVID-19. Yakut Medical Journal. 2022;(4):68-70. https://doi.org/10.25789/YMJ.2022.80.18